Pharmaceutical

ODM-212 by Orion for Solid Tumor: Likelihood of Approval

ODM-212 is under clinical development by Orion and currently in Phase I for Solid Tumor.

Dec 26, 2023 - 18:00
ODM-212 is under clinical development by Orion and currently in Phase I for Solid Tumor.
Read the original article

Tags:

Previous Article

RO-7566802 by Genentech USA for Solid Tumor: Likelihood of Approval

Next Article

KB-707 by Krystal Biotech for Solid Tumor: Likelihood of Approval

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

CD70 CAR-T by UTC Therapeutics for Refractory Chronic L...

Aug 10, 2023

We have a cure for hepatitis C — so why aren’t more people getting treatment?

We have a cure for hepatitis C — so why aren’t more peo...

Jun 30, 2023

Avenge Bio secures FDA orphan drug designation for mesothelioma therapy

Avenge Bio secures FDA orphan drug designation for meso...

Jun 17, 2023